BMS-986278 | m-entrepreneurship.com

Product Name :
BMS-986278

Search keywords :
BMS-986278

drugId :
null

Target Vo:
Lysophosphatidic acid receptor Edg-2

Target Vo Short Name :
LPAR1

Moa_Name:
Lysophosphatidic acid receptor Edg-2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bristol-Myers Squibb Company

Active Company_Name :
Bristol-Myers Squibb (China) Investment Co Ltd

Active Indication_Name:
Idiopathic Pulmonary Fibrosis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NF-KB p65 Antibody
Phospho-PLK1 (Thr210) Antibody
Wnt3a Antibody: Wnt3a Antibody is a non-conjugated and Rabbit origined Polyclonal antibody about 39 kDa, targeting to Wnt3a . It can be used for WB, IHC-P, IHC-F, IF, ELISA assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts